Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on May 1, 2025

BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting
Company to co-exhibit with strategic partner Venture Medical, LLC, highlighting collaborative innovation in chronic wound care management Three accepted scientific posters will feature BioStem’s advanced allograft portfolio POMPANO BEACH, Fla., May 01, …

Atea Pharmaceuticals to Host Virtual HCV KOL Panel on May 14, 2025
Panel to Discuss Current Challenges Encountered by Patients with HCV, Results from Atea’s Phase 2 Study of the Regimen of Bemnifosbuvir and Ruzasvir, and What a New Optimized HCV Therapy Could Provide for Prescribers and Patients Event to Replace Atea’s …

Aduro Engages Siemens to Deliver Advanced Automation for Hydrochemolytic™ Pilot Plant
LONDON, Ontario, May 01, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste …

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2025
― Enrollment complete in the 12 mg dose cohort (n=16) of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD); initiated the 20 mg dose cohort ― ― On track to provide clinical data from the 12 mg dose cohort in early Q3 2025 and the 20 mg …

Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates
1Q 2025 Total Revenue of $125.2M, a 15% Increase Year-over-Year at CER Expanding Portfolio through In-Licensing of DMX-200 Phase 3 Program for Rare Kidney Disease with Significant Market Potential in the U.S. Maintaining 2025 Guidance for Galafold, …

FDA Grants OKYO Pharma Fast Track Designation to Urcosimod for Neuropathic Corneal Pain
LONDON and NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod (formerly called OK-101) to treat NCP, an ocular condition associated with chronic …

Agios Reports First Quarter 2025 Financial Results and Recent Business Highlights
– U.S. Regulatory Filing Under Active Review for Approval of PYRUKYND® (mitapivat) in Thalassemia, with PDUFA Goal Date of September 7, 2025 – – Phase 3 RISE UP Study of Mitapivat in Sickle Cell Disease On Track, with Topline Results Expected in Late 2025 …

First Atlantic Nickel Featured in Article Highlighting Hydrogen Potential of Newfoundland and Labrador Nickel Deposits
VANCOUVER, British Columbia, May 01, 2025 (GLOBE NEWSWIRE) -- First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) ("First Atlantic" or the "Company") a Canadian mineral exploration company focused on developing its 100%-owned Atlantic Nickel …
![Best Sugar Daddy Apps [2025] Free Sugar Daddy Dating Apps To Meet Sugar Daddies And Sugar Babies Online](/images/pressrelease-small.png)
Best Sugar Daddy Apps [2025] Free Sugar Daddy Dating Apps To Meet Sugar Daddies And Sugar Babies Online
Las Vegas, Nevada, May 01, 2025 (GLOBE NEWSWIRE) -- Navigating the world of sugar dating apps requires knowledge, discretion, and careful platform selection. This comprehensive guide explores the top-rated sugar daddy apps, helping you make informed …

X4 Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates
4WARD Phase 3 chronic neutropenia trial in full swing; full enrollment on track for 3Q or 4Q 2025 and top-line data in 2H 2026 Additional analyses of mavorixafor clinical trial data increase confidence in successful outcome of 4WARD trial XOLREMDI® net U.S …

Revolutionizing Wireless PCVR: Virewirx Unveils VX60 Portable – 60 GHz mmWave Excellence for Latency-Free XR Experiences Anywhere
SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Virewirx, a leading innovator in 60 GHz mmWave wireless networking technology, announces the launch of its latest product: VX60 Portable, a compact, free-roam wireless XR solution. VX60 Portable powers high- …

Biosplice Announces First Patient Dosed in Phase 2 Trial of Cirtuvivint for Advanced Soft-Tissue Sarcomas
SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering advancements in small molecule inhibition of CDC-like kinases (CLK) and Dual-specificity tyrosine phosphorylation- …

Voice2Me.ai Unveils the World’s First Multimodal AI Voice Agents for ServiceNow—Live in Minutes, Not Months
Fairfax, Virginia, May 01, 2025 (GLOBE NEWSWIRE) -- Voice2Me.ai today announced the debut of the industry’s first multimodal AI agent platform for ServiceNow and beyond. Building on the company’s headless, ultra-secured architecture, the new release lets …

AB Science will publish its 2024 annual financial report on May 9, 2025
PRESS RELEASE THE COMPANY WILL PUBLISH ITS 2024 ANNUAL FINANCIAL REPORT ON 9 MAY 2025 Paris, May 1st 2025, 10am CET AB Science SA (Euronext - FR0010557264 - AB) today announced that it has postponed the publication of its 2024 annual financial report, …

AB Science publiera son rapport financier annuel 2024 le vendredi 9 mai 2025
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE LA PUBLICATION LE 9 MAI 2025 DE SON RAPPORT FINANCIER ANNUEL 2024 Paris, 1er mai 2025, 10h AB Science SA (Euronext - FR0010557264 - AB) annonce aujourd'hui le décalage de la publication de son rapport financier …

Son of Iconic Bogdanoff Twin To support $PUMPIT Community owned token initiative
Paris, France, May 01, 2025 (GLOBE NEWSWIRE) -- In a heartfelt tribute to the enduring legacy of the Bogdanoff twins on the cryptocurrency industry, Wenceslas Bogdanoff, son of the late Igor Bogdanoff, shares his views on the PUMPIT memecoin as a heartfelt …

Oculis to Present its Innovative Late-Stage Pipeline Candidates at Upcoming Ophthalmology Conferences
ZUG, Switzerland, May 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs …

SPEC Delivers SPECviewperf 15 Benchmark with New Graphics APIs and Workloads, Support for New Application Versions
GAINESVILLE, Va., May 01, 2025 (GLOBE NEWSWIRE) -- The Standard Performance Evaluation Corporation (SPEC), the trusted global leader in computing benchmarks, today announced the availability of the SPECviewperf 15 benchmark, a significant update to the …

SHORTFOMO Launches Creator Program in Dubai to Bridge Local Talent with Small Business Owners
DUBAI, UAE, May 01, 2025 (GLOBE NEWSWIRE) -- SHORTFOMO, the UAE’s leading video design agency known for its fast, punchy social content, has just announced the launch of its CREATOR program in Dubai—a new initiative that connects skilled content creators …

Synaptics and Murata Partner for Next-Generation Automotive Wireless Connectivity
SAN JOSE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: SYNA) and Murata Manufacturing today announced they are partnering to develop a next-generation turnkey wireless connectivity module for automotive Tier 1 suppliers and …